Cargando…
Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
An increased metabolic flux towards Warburg phenotype promotes survival, proliferation and causes therapeutic resistance, in leukemic cells. Hexokinase-II (HK-II) is expressed predominantly in cancer cells, which promotes Warburg metabolic phenotype and protects the cancer cells from drug-induced ap...
Autores principales: | Rai, Yogesh, Yadav, Priyanshu, Kumari, Neeraj, Kalra, Namita, Bhatt, Anant Narayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757186/ https://www.ncbi.nlm.nih.gov/pubmed/31506393 http://dx.doi.org/10.1042/BSR20190880 |
Ejemplares similares
-
Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003) -
Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stell Cell Compartments in Response to Curcumin and Daunorubicin
por: Mohammadi, Saeed, et al.
Publicado: (2017) -
Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without Toxicity
por: Aguiñiga-Sánchez, Itzen, et al.
Publicado: (2021) -
Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells
por: Tsuma-Kaneko, Mitsuyo, et al.
Publicado: (2018) -
Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
por: Han, Weidong, et al.
Publicado: (2011)